There may be significant delays for pretreatment testing (which should be managed by the referring center), arranging lodging, travel time, and insurance approval, as well as leukapheresis and CAR-T slot assignment.
← all excerpts
Recommendations for the effective use of T-cell-redirecting therapies: a Canadian consensus statement.
1
—
—